The marvel of percutaneous cardiovascular devices in the elderly.
Thanks to minimally invasive procedures, frail and elderly patients can also benefit from innovative technologies. More than 14 million implanted pacemakers deliver impulses to the heart muscle to regulate the heart rate (treating bradycardias and blocks). The first human implantation of defibrillators was performed in early 2000. The defibrillator detects cardiac arrhythmias and corrects them by delivering electric shocks. The ongoing development of minimally invasive technologies has also broadened the scope of treatment for elderly patients with vascular stenosis and aneurysmal disease as well as other complex vascular pathologies. The nonsurgical cardiac valve replacement represents one of the most recent and exciting developments, demonstrating the feasibility of replacing a heart valve by way of placement through an intra-arterial or trans-ventricular sheath. Percutaneous devices are particularly well suited for the elderly as the surgical risks of minimally invasive surgery are considerably less as compared to open surgery, leading to a shorter hospital stay, a faster recovery, and improved quality of life.
Department of Surgery, Laval University and Quebec Biomaterials Institute, CHUQ, Quebec, Canada.
Robert
R
Guidoin
Yvan
Y
Douville
Marie-Annick
MA
Clavel
Ze
Z
Zhang
Mark
M
Nutley
Philippe
P
Pîbarot
Guy
G
Dionne
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000628:therapy*; D002319:Cardiovascular System / Q000503:physiopathology*; D006351:Heart Valves / Q000503:physiopathology*; D006352:Heart Ventricles / Q000033:anatomy & histology*; D006801:Humans